Slingshot members are tracking this event:
GlycoMimetics (GLYC) Announces Dosing of First Patient in Phase I Trial of GMI-1271 in Multiple Myeloma
Slingshot Insights Explained
Sep 14, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Dosing Of First Patient, Phase I Trial, Gmi-1271, Multiple Myeloma